Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 25;11(2):156.
doi: 10.3390/children11020156.

Ultrasound in Pediatric Inflammatory Bowel Disease-A Review of the State of the Art and Future Perspectives

Affiliations
Review

Ultrasound in Pediatric Inflammatory Bowel Disease-A Review of the State of the Art and Future Perspectives

André Hoerning et al. Children (Basel). .

Abstract

Inflammatory bowel disease (IBD) comprises a group of relapsing, chronic diseases of the gastrointestinal tract that, in addition to adults, can affect children and adolescents. To detect relapses of inflammation, these patients require close observation, frequent follow-up, and therapeutic adjustments. While reference standard diagnostics include anamnestic factors, laboratory and stool sample assessment, performing specific imaging in children and adolescents is much more challenging than in adults. Endoscopic and classic cross-sectional imaging modalities may be invasive and often require sedation for younger patients. For this reason, intestinal ultrasound (IUS) is becoming increasingly important for the non-invasive assessment of the intestine and its inflammatory affection. In this review, we would like to shed light on the current state of the art and provide an outlook on developments in this field that could potentially spare these patients more invasive follow-up procedures.

Keywords: Crohn’s disease; optoacoustics; pediatric inflammatory bowel disease; ulcerative colitis; ultrasound.

PubMed Disclaimer

Conflict of interest statement

A.P.R. and F.K. are shared patent holders, together with iThera Medical GmbH (Munich, Germany), for the optoacoustic imaging system/software described in this study. F.K. is a member of the clinical advisory board of iThera Medical GmbH (Munich, Germany).

Figures

Figure 1
Figure 1
Ultrasound for assessment of inflammatory bowel diseases (A,B) Schematic cartoon of standard imaging locations for disease activity assessment in inflammatory bowel diseases as follows: terminal ileum and ascending, transverse, descending, and sigmoid colon. In healthy subjects, the intestinal wall of the terminal ileum/colon is thinner than 2 mm and it exceeds 2–2.5 mm in inflamed segments in IBD patients. (C,D) Exemplary B-mode and color Doppler images of healthy and inflamed segments of the sigmoid colon with exemplary bowel wall measurements. Displayed is a healthy child and one pediatric patient with UC. B-mode images show enlarged submucosa in the UC patient with increased blood flow measured by color Doppler. IBD = inflammatory bowel disease, Ti = terminal ileum. Created with https://www.biorender.com/ (accessed on 22 January 2024).
Figure 2
Figure 2
Multispectral optoacoustic imaging—molecular sensitive ultrasound. (A) Cartoon of bedside multispectral optoacoustic tomography (MSOT) to assess molecular tissue composition. (B,C) Exemplary reflected-ultrasound computed tomography (RUCT) and MSOT images of a pediatric patient with ulcerative colitis. RUCT enables real-time guidance of the investigator. Spectral unmixing of MSOT data allows differentiation and quantification of oxygenated (red) and deoxygenated (blue) blood within the bowel wall (green, region of interest). Increased levels of hemoglobin correlate with disease activity and might serve as surrogate biomarkers. Created with https://www.biorender.com/ (accessed on 22 January 2024).

Similar articles

Cited by

References

    1. Graham D.B., Xavier R.J. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578:527–539. doi: 10.1038/s41586-020-2025-2. - DOI - PMC - PubMed
    1. Chang J.T. Pathophysiology of Inflammatory Bowel Diseases. N. Engl. J. Med. 2020;383:2652–2664. doi: 10.1056/NEJMra2002697. - DOI - PubMed
    1. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317. doi: 10.1038/nature10209. - DOI - PMC - PubMed
    1. Schaffler H., Kaschitzki A., Alberts C., Bodammer P., Bannert K., Koller T., Warnke P., Kreikemeyer B., Lamprecht G. Alterations in the mucosa-associated bacterial composition in Crohn’s disease: A pilot study. Int. J. Color. Dis. 2016;31:961–971. doi: 10.1007/s00384-016-2548-z. - DOI - PubMed
    1. Neurath M.F. Host-microbiota interactions in inflammatory bowel disease. Nat. Reviews. Gastroenterol. Hepatol. 2020;17:76–77. doi: 10.1038/s41575-019-0248-1. - DOI - PubMed

LinkOut - more resources